Lidocaine Hydrochloride Monohydrate

Product NDC: 69420-1230
Requested package NDC: 69420-1230-2
11-digit product format: 694201230
Labeler code: 69420
Product ID: 69420-1230_47b16c49-2a6b-481d-9c46-1ce4863769e6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lidocaine Hydrochloride Monohydrate
Dosage form: POWDER
Route: INTRADERMAL
Labeler: SA3, LLC
Application: NDA022114
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2019-01-01
Marketing end: 0000-00-00
Substance: LIDOCAINE HYDROCHLORIDE
Active strength: 1 mg/1
Pharmacologic classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	69420-1230	69420-1230-2	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022114-001	ZINGO	LIDOCAINE HYDROCHLORIDE	0.5MG	SYSTEM / INTRADERMAL			2007-08-16

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Submission date
N022114-001	8540665	2029-10-22	U-1438	2013-10-09
N022114-001	9358338	2035-04-27	U-1870	2016-07-06
N022114-001	9370622	2035-09-28	U-1870	2016-07-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022114-001	ZINGO	0.5MG	SYSTEM / INTRADERMAL	2007-08-16	`f41ea6bd6efb…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022114-001	9358338	2035-04-27	U-1870	2016-07-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022114-001	9370622	2035-09-28	U-1870	2016-07-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022114-001	8540665	2029-10-22	U-1438	2013-10-09	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
69420-1230-1	2022-02-14	These highlights do not include all the information needed to use Lidocaine Hydrochloride Monohydrate powder intradermal injection system safely and effectively. See full prescribing information for Lidocaine Hydrochloride Monohydrate powder intradermal injection system. Lidocaine Hydrochloride Monohydrate 0.5mg powder intradermal injection system Initial U.S. Approval: 1948
69420-1230-2	2022-02-14	These highlights do not include all the information needed to use Lidocaine Hydrochloride Monohydrate powder intradermal injection system safely and effectively. See full prescribing information for Lidocaine Hydrochloride Monohydrate powder intradermal injection system. Lidocaine Hydrochloride Monohydrate 0.5mg powder intradermal injection system Initial U.S. Approval: 1948
69420-1230-1	2022-01-28	These highlights do not include all the information needed to use Lidocaine Hydrochloride Monohydrate powder intradermal injection system safely and effectively. See full prescribing information for Lidocaine Hydrochloride Monohydrate powder intradermal injection system. Lidocaine Hydrochloride Monohydrate 0.5mg powder intradermal injection system Initial U.S. Approval: 1948
69420-1230-2	2022-01-28	These highlights do not include all the information needed to use Lidocaine Hydrochloride Monohydrate powder intradermal injection system safely and effectively. See full prescribing information for Lidocaine Hydrochloride Monohydrate powder intradermal injection system. Lidocaine Hydrochloride Monohydrate 0.5mg powder intradermal injection system Initial U.S. Approval: 1948

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
69420-1230-1	EA - Each	69420-1230	427fdee6-b85f-4ca5-9116-f8a0ba8b7c21	1	2019-02-13

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V13007Z41A	LIDOCAINE HYDROCHLORIDE	6108-05-0	LIDOCAINE HYDROCHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69420-1230-2	69420123002	12 POUCH in 1 CARTON (69420-1230-2) > 1 POWDER in 1 POUCH	12 pouch	2019-01-01	0000-00-00	No	No	Current